A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring
NCT06797206 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-10-01
Summary
In this study, investigators aim to study in detail the physical (including nutritional and pulmonary) and mental health of females with cystic fibrosis (CF) planning a pregnancy, during pregnancy, and in the early parenthood period.
Additionally the health of offspring in infancy and early life will be studied to understand if further screening investigations or clinical care models should be part of clinical guidelines
Conditions
- Cystic Fibrosis (CF)
- Pregnancy
- Infant, Newborn
- Exposure During Pregnancy
Sponsors & Collaborators
-
Cystic Fibrosis Trust
collaborator OTHER - collaborator OTHER
-
Imperial College London
collaborator OTHER -
Royal Brompton & Harefield NHS Foundation Trust
lead OTHER
Principal Investigators
-
Imogen Felton · Royal Brompton Hospital and NHLI Imperial College London
-
Jane Davies · Royal Brompton Hospital and NHLI Imperial College London
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-12
- Primary Completion
- 2028-04-30
- Completion
- 2028-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis
NCT00014768 ·Status: TERMINATED
-
Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis
NCT02847208 ·Status: COMPLETED
-
Prospective Study of the Phenotypic Expression of Cystic Fibrosis (CF) Screened Positive Newborns With an Atypical Form of CF (DPAM)
NCT02869932 ·Status: COMPLETED ·Phase: NA
-
MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis
NCT04620096 ·Status: COMPLETED
-
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
NCT04568980 ·Status: COMPLETED
-
Parenting Concerns in Patients With Cystic Fibrosis (MucoPar)
NCT04133246 ·Status: COMPLETED ·Phase: NA
-
Puberty in Girls Followed for Cystic Fibrosis
NCT02562911 ·Status: COMPLETED
-
Assessment of Patients Not Concluded After Neonatal Screening of Cystic Fibrosis.
NCT06300567 ·Status: NOT_YET_RECRUITING
-
Understanding Gut Symptoms in People With Cystic Fibrosis
NCT05934656 ·Status: RECRUITING
-
Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers
NCT04940533 ·Status: NOT_YET_RECRUITING
-
Perceptions of the CF Screening Protocol Incorporating NGS
NCT06299566 ·Status: COMPLETED
-
Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment
NCT06327802 ·Status: RECRUITING
-
Baby Observational and Nutritional Study
NCT01424696 ·Status: COMPLETED
-
Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
NCT06507956 ·Status: RECRUITING
-
Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis
NCT01686672 ·Status: COMPLETED ·Phase: NA
-
Response to CFTR Modulators in CF Patients Under 18 Years
NCT04301856 ·Status: RECRUITING
-
Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening
NCT02270476 ·Status: RECRUITING
-
Concerns of Children Whose Parents Have Cystic Fibrosis
NCT04702386 ·Status: COMPLETED
-
Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis
NCT03450720 ·Status: COMPLETED ·Phase: PHASE1
-
Combating Diagnostic Wandering and Impasse for Cystic Fibrosis
NCT05654480 ·Status: UNKNOWN
-
A CFit Study - Acute Exercise
NCT03237767 ·Status: TERMINATED ·Phase: NA
-
Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis
NCT01401439 ·Status: COMPLETED
-
Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI
NCT04391322 ·Status: ACTIVE_NOT_RECRUITING
-
Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
NCT04463628 ·Status: COMPLETED
-
Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways
NCT00700050 ·Status: COMPLETED